As a leading biopharmaceutical company, we continue to invent new approaches that save and improve lives so that people can positively contribute to a healthier and more hopeful world.
Letter from Our CEO
“Whether it is by inventing breakthrough medicines and vaccines that address critical areas of growing, global medical need, improving access to health care, protecting the environment, or engaging employees, we are committed to making the world a better place today and for generations to come.”
— Kenneth C. Frazier, Chairman and Chief Executive Officer
Areas of Focus
Our corporate responsibility approach is aligned with the company’s focus on invention, and underscores our commitment to overcoming the greatest obstacles to health and well-being, developing and rewarding our employees, protecting the environment and operating with the highest standards of ethics and transparency.
Addressing Our Most Important Issues
Within our four focus areas, we have identified the topics that are most critical to our business and to our external stakeholders, based on a formal corporate responsibility materiality assessment.
Expanding Our Impact
We have recently expanded our social investments through impact investing. This involves making financial investments in companies, organizations and funds with the intent to generate social and environmental impact along with a financial return.
One example of this is our recent $5 million investment in the Abraaj Growth Markets Health Fund, which focuses on health infrastructure expansion for low- and middle-income populations.
Through our philanthropic contributions and volunteering, we strive to find sustainable solutions to key global health challenges and to strengthen communities where our employees live and work.
Our program investments aim to support interventions that have shown evidence of effectiveness in advancing the quality of health services delivery, reducing health care disparities, fostering innovation in the delivery of health care, and empowering patients as active participants in managing their own health.
MSD for Mothers: Committed to Saving Lives
MSD for Mothers is our company’s 10-year, $500 million initiative that applies our scientific and business expertise, as well as our financial resources, to reduce preventable maternal mortality worldwide by catalyzing transformative solutions. We are applying private-sector approaches to improve access to quality maternal health care that women receive in health facilities at the time of childbirth, and to improve access to family planning services.
Awards & Recognition
We have been recognized for our commitment to corporate responsibility.
Named as a constituent of the FTSE4Good Index
Ranked among Corporate Knights’ 2017 Global 100 Most Sustainable Corporations in the World
The SDGs & Our Approach
Our corporate responsibility strategy includes our alignment with the UN Sustainable Development Goals (SDGs).
While all of the SDGs are essential to fostering sustainable development, and are being addressed by our company, we have prioritized eight global goals as those where we are positioned to have the biggest impact.